Article

Cancer Immunity, Vol. 7, p. 2 (6 February 2007) Submitted: 20 December 2006. Accepted: 3 January 2007.

Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer

Nicholas C. Souders*, Duane A. Sewell*, Zhen-Kun Pan*, S. Farzana Hussain, Alexander Rodriguez, Anu Wallecha and Yvonne Paterson

Department of Microbiology, University of Pennsylvania, Philadelphia, PA, 19104, USA

*These authors contributed equally to this work

Communicated by: PK Srivastava

Keywords: transgenic mice, vaccination, cytotoxic T cells, tumor immunity, tolerance

Abstract

We have created a transgenic mouse with tissue-specific expression of the human papilloma virus (HPV) 16 E6 and E7 oncoproteins in the thyroid as a model of HPV transformed cancer. The expression of the transgenes results in the formation of palpable thyroid tumors. E7 is not expressed in other tissues but is expressed in medullary thymic epithelial cells, which have been implicated in the control of negative selection. We show that Listeria-based vaccines against E7 can induce the regression of solid implanted tumors in the transgenic mice, although at a lower frequency than in wild type (WT) mice. E7-specific CD8+ T cells induced in transgenic mice are of both lower avidity and lower frequency when compared to the WT mice. In this model, Listeria-based vaccines against E7 appear to be overcoming central tolerance by expanding low avidity CD8+ T cells specific for E7 that are not deleted during thymopoesis and can eliminate solid tumors.